Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials.
This combined analysis of results from the two Phase III, randomized, double-blind controlled studies of E-BPO cream, 5%, showed it was efficacious, tolerable, and safe, regardless of age.
Authors
- Ori Nov
- Ofra Levy-Hacham
- Jeremy Sugarman (ORCID: https://orcid.org/0000-0001-7022-8332)
- Lawrence J. Green (ORCID: https://orcid.org/0000-0002-1295-9249)
- Bill Andriopoulos
- Hilary E. Baldwin (ORCID: https://orcid.org/0009-0002-3540-3670)
- Neal Bhatia (ORCID: https://orcid.org/0000-0001-7448-7809)
- William Philip Werschler
Institutions
- University of California, San Francisco (US)
- George Washington University (US)
- Therapeutics Clinical Research (US)
- Galderma (United States) (US)
- Sol-Gel Technologies (Israel) (IL)
- Rockwood Clinic (US)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- Citations
- 1
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.53
Funders
- Galderma